Pembroke Management’s Charles River Laboratories CRL Stock Holding History

Pembroke Management’s Portfolio CRL Stock Details CRL Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-35,633	Closed	-$13.4M	–	70
2021 Q4	$13.4M	Sell	35,633 -34,381	-49%	-$13M	0.98%	43
2021 Q3	$28.9M	Buy	70,014 +255	+0.4%	+$105K	2.18%	19
2021 Q2	$25.8M	Sell	69,759 -14,302	-17%	-$5.29M	2.02%	20
2021 Q1	$24.4M	Sell	84,061 -32,076	-28%	-$9.3M	2.03%	19
2020 Q4	$29M	Sell	116,137 -9,202	-7%	-$2.3M	2.43%	13
2020 Q3	$28.4M	Buy	125,339 +9	+0%	+$2.04K	3.09%	5
2020 Q2	$21.9M	Sell	125,330 -7,258	-5%	-$1.27M	2.57%	12
2020 Q1	$16.7M	Buy	132,588 +14,491	+12%	+$1.83M	2.66%	10
2019 Q4	$18M	Sell	118,097 -16,943	-13%	-$2.59M	1.53%	31
2019 Q3	$17.9M	Buy	135,040 +31,689	+31%	+$4.19M	1.94%	24
2019 Q2	$14.7M	Sell	103,351 -884	-0.8%	-$125K	1.55%	34
2019 Q1	$15.1M	Buy	104,235 +34,900	+50%	+$5.07M	1.64%	28
2018 Q4	$7.85M	Sell	69,335 -18,450	-21%	-$2.09M	1.07%	41
2018 Q3	$11.8M	Sell	87,785 -32,100	-27%	-$4.32M	1.21%	39
2018 Q2	$13.5M	Sell	119,885 -3,800	-3%	-$427K	1.38%	35
2018 Q1	$13.2M	Buy	123,685 +46,150	+60%	+$4.93M	1.4%	33
2017 Q4	$8.49M	Sell	77,535 -50,000	-39%	-$5.47M	0.87%	49
2017 Q3	$13.8M	Sell	127,535 -92,800	-42%	-$10M	1.35%	40
2017 Q2	$22.3M	Sell	220,335 -51,400	-19%	-$5.2M	1.98%	16
2017 Q1	$24.4M	Buy	271,735 +15,900	+6%	+$1.43M	2.4%	13
2016 Q4	$19.5M	Buy	255,835 +29,300	+13%	+$2.23M	1.99%	18
2016 Q3	$18.9M	Sell	226,535 -90,900	-29%	-$7.58M	1.87%	23
2016 Q2	$26.2M	Buy	317,435 +16,000	+5%	+$1.32M	2.39%	14
2016 Q1	$22.9M	Sell	301,435 -13,000	-4%	-$987K	2.01%	24
2015 Q4	$25.3M	Sell	314,435 -32,900	-9%	-$2.64M	2.04%	21
2015 Q3	$22.1M	Buy	347,335 +87,235	+34%	+$5.54M	1.64%	32
2015 Q2	$18.3M	Buy	260,100 +30,200	+13%	+$2.12M	1.16%	38
2015 Q1	$18.2M	Buy	229,900 +28,500	+14%	+$2.26M	1.15%	37
2014 Q4	$12.8M	Buy	+201,400	New	+$12.8M	0.79%	39